Navigation Links
Cleveland Clinic Unveils 'Top 10' Medical Innovations For 2008
Date:10/3/2007

Ten Emerging Technologies Will Shape Healthcare Next Year, Hospital

Predicts

CLEVELAND, Oct. 3 /PRNewswire/ -- Cleveland Clinic today announced its Top 10 Medical Innovations list, highlighting technologies which will likely have a big impact on healthcare in 2008.

The list of breakthrough devices and therapies was selected by a panel of Cleveland Clinic physicians and scientists and was unveiled during Cleveland Clinic's 2007 Medical Innovation Summit, which is currently underway. They include therapies for valvular heart disease, unusually high cholesterol, and severe neurologic disorders.

"These innovations represent exciting technologies which may have a major impact in clinical practice in the near future," said Tomislav Mihaljevic, M.D., who chaired the Top 10 Medical Innovations List. "We believe this list represents the best, innovative approaches in health care today affecting some of the most prevalent diseases affecting millions of patients world-wide."

The Top 10 Medical Innovations for 2008 are:

10. Dual energy source computed tomography (CT) imaging: The dual source CT features two X-ray sources and two radiation detectors which allow for imaging of patients more quickly and with less radiation. The speed at which the dual-source scanner operates allows physicians image patients with high or irregular heart rates, which used to be significant limitation of this technology.

9. Engineered cartilage products for joint repair: The use of biologic and engineering principles to design natural biomaterials that are used to replace joint cartilage tissue that is damaged from injury or arthritis. The materials are surgically implanted into the joint with the intent to restore the damaged cartilage and avoid artificial joint replacement.

8. Implanted device allowing neural control of objects by the severely disabled: Novel communication interfaces are being developed to provide the ability to control devices and to potentially restore limb movements to individuals with spinal cord injuries, stroke, ALS, as well as other central nervous system injuries. This interface system is designed to restore functionality for severely motor-impaired individuals.

7. Image fusion for diagnostic and therapeutic use: Used to diagnose medical problems, both anatomic and physiologic in nature, as well as to assist minimally invasive procedures - such as stent placement or tumor ablation.

6. Live attenuated influenza vaccine for children as young as six months: Nasal drops containing live attenuated flu can be used as a vaccine in lieu of needles, and provide effective protection from influenza for this high-risk population.

5. New oral anticoagulant drugs for treating and prevent thrombosis: Newer anticoagulant treatments, which include low molecular weight heparins, are being introduced with the goal of curbing complications such as bleeding and thrombosis.

4. Convergence of advances in genome scanning and informatics to support clinical applications: Genetic testing that can be used to develop personalized risk assessments and disease management plans for variety of genetically caused diseases.

3. RNA-based therapeutics: This particular innovation uses RNA antisense technology to treat patients who are unable to reach their targeted cholesterol levels with statins alone or who are statin intolerant. The therapy is intended to reduce the production of ApoB-100, a protein that carries certain forms of cholesterol and triglycerides in the bloodstream.

2. Percutaneous aortic heart valves: For high risk patients, a technique has been developed which involves inserting a new balloon expandable wire mesh valve with internal valve leaflets. The valve is inserted through a groin or small chest wall incision and then fed up through a catheter into position with X-ray screening and the balloon inflated to secure the new valve.

1. Flexible intralumenal robotics: A novel catheter-based technology that allows precise remote manipulations within the intra-luminal space with precision and reproducibility, which would surpass human capabilities. This technology is likely to have applications in urology, cardiology, cardiac surgery and other specialties.

"Cleveland Clinic scientists and clinicians are engaged in a continuous dialogue about how to provide patients with the best possible care. Their constant interaction, combined with the Clinic's role as a site of basic science and as an end user of medical products, provides a unique perspective for evaluating what will be the novel and next generation therapeutics and products," said Christopher Coburn, Executive Director, CCF Innovations, Cleveland Clinic's technology commercialization arm. "The second annual Top 10 list is a result of a survey of dozens of Cleveland Clinic thought leaders and we hope it stimulates widespread discussions on innovation and new technology."

Four major criteria served as the basis for qualifying and selecting the Top 10 Medical Innovations. Nominated innovations were required to:

- Have significant potential for short-term clinical impact (either a major improvement in patient benefit or an improved function that enhances healthcare delivery).

- Have a high probability of success.

- Be on the market or close to being introduced.

- Have sufficient data available to support its nomination.

The Top 10 Medical Innovations for 2008 were announced Oct. 3 at the annual Cleveland Clinic Medical Innovation Summit. A panel of eight Cleveland Clinic thought leaders and a moderator discussed each technology and its reason for inclusion during a panel session.

In developing the Top 10, Cleveland Clinic enlisted the expertise of AlixPartners, LLP, an independent international management consulting firm. AlixPartners led the process to probe the opinions of Cleveland Clinic physicians and researchers, create a field of nominated innovative technologies for consideration, and develop a consensus perspective on the Top 10 Medical Innovations for 2008.

For more information about this year's Medical Innovation Summit and the conference agenda, visit http://www.clevelandclinic.org/innovations/summit/default.htm.

About CCF Innovations

CCF Innovations, the technology commercialization arm of Cleveland Clinic, organizes the Medical Innovation Summit and stewards the Clinic's technology innovation strategy. It enhances product-oriented innovation throughout Cleveland Clinic and transforms promising therapies, devices and diagnostics into beneficial medical products, via spin-off companies, licensees and equity partnerships.

About Cleveland Clinic

Cleveland Clinic, located in Cleveland, Ohio, is a not-for-profit multispecialty academic medical center that integrates clinical and hospital care with research and education. Cleveland Clinic was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. U.S. News & World Report consistently names Cleveland Clinic as one of the nation's best hospitals in its annual "America's Best Hospitals" survey. Approximately 1,800 full-time salaried physicians and researchers at Cleveland Clinic and Cleveland Clinic Florida represent more than 100 medical specialties and subspecialties. In 2006, there were 3.1 million outpatient visits to Cleveland Clinic. Patients came for treatment from every state and from more than 80 countries. There were more than 53,000 hospital admissions to Cleveland Clinic in 2006. Cleveland Clinic's Web site address is http://www.clevelandclinic.org.


'/>"/>
SOURCE Cleveland Clinic
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. The Cleveland Clinic Expands Its Services across the World via the Net
2. Satellite Clinic To Be Set Up in Toronto By Ohio-Based Cleveland Clinic
3. Indo-American Doctor Fired By Cleveland Clinic
4. Scientists plan human cloning clinic in the United States
5. How do patients benefit of clinical trials
6. Magnetic resonance angiography in clinical medicine
7. Clinical trials need to be more frank
8. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
9. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
10. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
11. Clinical Comparisons Between ADHD Drugs Are Less
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... , ... Gout is like no other joint pain. It strikes suddenly, like ... swelling and redness. It is triggered by the crystallization of uric acid within the ... susceptible, according to the February 2016 issue of Harvard Men's Health Watch. , The ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact Phyllis ... Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning author ... memory. The book’s publication date is March 16, 2016. A free review copy ...
(Date:2/10/2016)... (PRWEB) , ... February 10, ... ... Florida – 1 UNF Drive, Jacksonville, FL 32224, February 26th: Amateur & ... 27th: Elite Division - Time: 7:00pm – 10:00pm | Ticket Prices $30, ...
(Date:2/10/2016)... ... February 09, 2016 , ... A new leadership team for ... FHU President Joe Wiley made the announcement Monday night, Feb. 8, prior to the ... graduate of FHU and the creator of GO! Camp, has been named director. Gayle ...
(Date:2/10/2016)... ... February 10, 2016 , ... It’s that time of year when most people ... the Interscholastic Athletic Association of Maryland (IAAM), Hall of Fame athlete and Garrison Forest ... cast aside. , That’s why one of her first decisions when her IAAM two-year ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... India , February 10, 2016 ... The "Personalized Medicine, Targeted Therapeutics and Companion Diagnostic ... Trends, Technologies, Participants, and Environment" research report indicates ... worth over $149 billion by 2020 growing at ... up of companion diagnostics and targeted therapeutics and ...
(Date:2/10/2016)... LONDON , February 10, 2016 ... window and M 1 receptor selectivity   ... Heptares StaR® technology, which has entered clinical development ... patients with dementia and schizophrenia.   --> ... StaR® technology, which has entered clinical development as ...
(Date:2/9/2016)... Feb. 9, 2016  Misonix, Inc. (NASDAQ: ... designs, manufactures and markets innovative therapeutic ultrasonic products ... cosmetic surgery, laparoscopic surgery and other surgical applications, ... and the first half of fiscal year 2016 ... --> --> Highlights for the ...
Breaking Medicine Technology: